Claudin 18.2
Tight junction protein expressed in gastric and pancreatic cancers. Targeted by zolbetuximab (approved) and emerging CAR-T therapies including CT041 in China.
No Clinical Trials found for this biomarker.
Tight junction protein expressed in gastric and pancreatic cancers. Targeted by zolbetuximab (approved) and emerging CAR-T therapies including CT041 in China.
No Clinical Trials found for this biomarker.